Skip to main content
Premium Trial:

Request an Annual Quote

Gail Page, Debra Young, William Sullivan

Premium
Vermillion president and CEO Gail Page made $808,625 in total compensation in 2007, down 8 percent from $878,837, according to a proxy statement filed with the US Securities and Exchange Commission last week.
 
In April 2007, Vermillion’s board voted to increase her base salary to $364,000 from $350,000, raising her base salary for the whole year to $360,958. Last year, Page also received $30,508 as car compensation, but did not receive a bonus. In 2006 her bonus was $50,000.
 
According to the filing, Debra Young, who resigned as Vermillion’s vice president and CFO in November, is receiving severance payments totaling $112,750, and COBRA coverage. William Sullivan, who resigned as vice president of corporate operations last November, received a lump sum severance payment of $37,417. He is also receiving COBRA coverage.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.